ÂÜÀòÂÒÂ×

Nerymar Ortiz-Otero is currently a Senior Manager in Clinical Biomarker at Moderna, focusing on oncology since 2024. Previously, Nerymar served as a Translational Scientist II at Ikena Oncology from 2021 to 2024, overseeing clinical study progression for multiple oncology programs and implementing clinical biomarker assays. Nerymar's background includes a Postdoctoral Research Fellow position at Vanderbilt University, where research concentrated on circulating tumor cells and cancer-associated fibroblasts in head and neck cancer patients. As a Graduate Student at Cornell University, Nerymar earned a PhD in Biomedical Engineering, investigating the release of tumor-related cells in cancer patients. Early research experience includes a research assistant role at the University of Puerto Rico-Mayaguez, developing a metagenomics library, and an internship at Weill Cornell Medical College, gaining exposure to neuro-oncology. Academic credentials feature a Bachelor of Science in Industrial Biotechnology from the University of Puerto Rico-Mayaguez.